Evidence map›Paper›PMID 25822038›Full record

ArticleInternational journal of clinical pharmacy2015

Diagnostic evaluation and risk factors for drug allergies in children: from clinical history to skin and challenge tests.

Tugba Arikoglu, Gulen Aslan, Sehra Birgul Batmaz, Gulcin Eskandari, Ilter Helvaci, Semanur Kuyucu

Abstract read
PubMed Publisher
In one paragraph

Article in International journal of clinical pharmacy, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed.

  1. Evaluation of pediatric patients with drug allergy confirmed by in vivo diagnostic tests.Pediatric allergy and immunology : official publication of the European Society of Pediatric Allergy and Immunology · 2026
    Article
  2. Review
  3. Article
  4. Article
  5. Review
  6. Review
  7. Article
  8. Altered vaginal microbiome and relative co-abundance network in pregnant women with penicillin allergy.Allergy, asthma, and clinical immunology : official journal of the Canadian Society of Allergy and Clinical Immunology · 2020
    Article
  9. Article
  10. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Tugba ArikogluDepartment of Pediatric Allergy and Immunology, Faculty of Medicine, Mersin University, Çiftlikköy, Yenişehir, 33343, Mersin, Turkey, arikoglutugba@yahoo.com.
Gulen Aslan
Sehra Birgul Batmaz
Gulcin Eskandari
Ilter Helvaci
Semanur Kuyucu

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundParent or self-reported drug allergy claims frequently overestimate the real incidence of hypersensitivity reactions. A detailed and algorithmic diagnostic evaluation of drug reactions may allow a proper diagnosis.

objectiveThe aim of this study was to determine the confirmation rates and risk factors for confirmed allergic drug reactions in children.

settingMersin University Hospital in Turkey.

methodThe study consisted of children between ages of 8 months and 18 years with the history of suspected drug allergy as reported by the clinician or the patients. Parents were interviewed by a clinician to complete questionnaires that included questions about demographic data and characteristics of index drug reaction. Immediate reactions (IRs) were assessed with immediate-reading skin prick (SPT) and intradermal tests (IDT). Nonimmediate reactions (NIRs) were assessed with SPT, both early and delayed reading of IDT and patch tests. In case of negative skin tests, drug provocation tests were performed. The possible risk factors for confirmed drug allergy in univariate analysis (p < 0.1) were entered into the multivariate logistic regression analysis to determine independent predictors.

main outcome measure(1) Confirmation rates of drug allergy (2) Risk factors related to confirmed drug allergy in children.

resultsWe evaluated a total of 180 suspected drug allergy reactions in 97 children, mainly to antibiotics, non-steroidal anti-inflammatory drugs (NSAIDs) and anticonvulsants. Among all suspected allergic drug reactions, 97 (53.9 %) were immediate type and 83 (46.1 %) were non-immediate type. The average time interval between the reaction and allergologic work-up was 5 months. Drug allergy confirmation rates were 30.1 % for beta-lactams, 27.2 % for non-betalactams, 21.1 % for NSAIDs and 30 % for anticonvulsants. Eight of 54 confirmed NIRs showed positivity on immediate skin tests. Regulatory T cells, TGF-β and IL-10 levels were not different between groups with and without confirmed drug allergy. A strong family and personal history of drug allergy were found to be significantly related to the confirmed allergic drug reactions.

conclusionParent or self-reported drug allergy should be evaluated with a standardized diagnostic work-up before strict prohibitions are made. In addition, family and personal histories of drug allergy were significant risk factors related to allergic drug reactions in children.

Indexed as

AdolescentAnti-Bacterial AgentsAnticonvulsantsAnti-Inflammatory Agents, Non-SteroidalChildChild, PreschoolDrug HypersensitivityFemaleHumansHypersensitivity, DelayedHypersensitivity, ImmediateInfantInterviews as TopicMaleParentsRisk FactorsAnti-Bacterial AgentsAnticonvulsantsAnti-Inflammatory Agents, Non-Steroidal

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.